CDA-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CDA-2, covering 2017-11-08 to 2017-11-08. Get the full timeline:
Most recent: Clinical Trial Update: Myelodysplastic Syndrome--CDA-2 Hematological Improvement National Affirmation Study [Phase 4]